The biomarker revolution.
作者信息
Schisterman Enrique F, Albert Paul S
机构信息
Epidemiology Branch, Division of Epidemiology, Statistics and Prevention Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6100 Executive Boulevard Room 7B03, Bethesda, MD 20892-7510, USA.
出版信息
Stat Med. 2012 Sep 28;31(22):2513-5. doi: 10.1002/sim.5499.
Abstract
摘要
相似文献
1
The biomarker revolution.生物标志物革命。
Stat Med. 2012 Sep 28;31(22):2513-5. doi: 10.1002/sim.5499.
2
Assessment of skewed exposure in case-control studies with pooling.合并病例对照研究中偏倚暴露的评估。
Stat Med. 2012 Sep 28;31(22):2461-72. doi: 10.1002/sim.5351. Epub 2012 Mar 22.
3
Evaluating prognostic accuracy of biomarkers in nested case-control studies.评估巢式病例对照研究中生物标志物的预后准确性。
Biostatistics. 2012 Jan;13(1):89-100. doi: 10.1093/biostatistics/kxr021. Epub 2011 Aug 19.
4
Statistical considerations in combining biomarkers for disease classification.用于疾病分类的生物标志物组合中的统计学考量。
Dis Markers. 2004;20(2):45-51. doi: 10.1155/2004/214152.
5
Likelihood-based methods for regression analysis with binary exposure status assessed by pooling.基于似然比的方法用于通过合并来评估二元暴露状态的回归分析。
Stat Med. 2012 Sep 28;31(22):2485-97. doi: 10.1002/sim.4426. Epub 2012 Mar 13.
6
Conditional estimation after a two-stage diagnostic biomarker study that allows early termination for futility.两阶段诊断性生物标志物研究后的条件估计，该研究允许因无效而提前终止。
Stat Med. 2012 Feb 28;31(5):420-35. doi: 10.1002/sim.4430. Epub 2012 Jan 12.
7
Sample size calculation for comparing two ROC curves.比较两条 ROC 曲线的样本量计算。
Pharm Stat. 2024 Jul-Aug;23(4):557-569. doi: 10.1002/pst.2371. Epub 2024 Feb 28.
8
Non-response models for the analysis of non-monotone non-ignorable missing data.用于分析非单调不可忽略缺失数据的无应答模型。
Stat Med. 1997;16(1-3):21-37. doi: 10.1002/(sici)1097-0258(19970115)16:1<21::aid-sim470>3.0.co;2-f.
9
Statistical flaw in SURUSS model.
Prenat Diagn. 2004 Sep;24(9):753-4. doi: 10.1002/pd.930.
10
A measure of the performance of biomarkers for disease.
Cancer Biomark. 2006;2(3-4):145-50. doi: 10.3233/cbm-2006-23-406.
引用本文的文献
1
Brain-derived neurotrophic factor (BDNF): an effect biomarker of neurodevelopment in human biomonitoring programs.脑源性神经营养因子（BDNF）：人类生物监测项目中神经发育的效应生物标志物。
Front Toxicol. 2024 Jan 10;5:1319788. doi: 10.3389/ftox.2023.1319788. eCollection 2023.
2
Managing the moral expansion of medicine.管理医学的道德扩张。
BMC Med Ethics. 2022 Sep 22;23(1):97. doi: 10.1186/s12910-022-00836-2.
3
Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications.气道疾病中液体生物标志物的诊断准确性：迈向即时护理应用
Front Med (Lausanne). 2022 Jun 6;9:855250. doi: 10.3389/fmed.2022.855250. eCollection 2022.
4
Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer's Disease: The Paradigmatic Example of CSF.阿尔茨海默病生物标志物临床验证中的方法学问题：脑脊液的典型实例
Front Aging Neurosci. 2019 Oct 17;11:282. doi: 10.3389/fnagi.2019.00282. eCollection 2019.
5
An Empirical Validation of the Within-subject Biospecimens Pooling Approach to Minimize Exposure Misclassification in Biomarker-based Studies.基于生物标志物的研究中最小化暴露错分类的个体内生物样本混合方法的实证验证。
Epidemiology. 2019 Sep;30(5):756-767. doi: 10.1097/EDE.0000000000001056.
6
Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping.神经免疫性疾病中枢神经系统生物标志物研究中的前景、进展与陷阱：脑脊液免疫表型分析的作用
Semin Pediatr Neurol. 2017 Aug;24(3):229-239. doi: 10.1016/j.spen.2017.08.001. Epub 2017 Aug 12.
7
Within-subject Pooling of Biological Samples to Reduce Exposure Misclassification in Biomarker-based Studies.生物样本的个体内合并以减少基于生物标志物研究中的暴露错误分类
Epidemiology. 2016 May;27(3):378-88. doi: 10.1097/EDE.0000000000000460.
本文引用的文献
1
Estimation of gene-environment interaction by pooling biospecimens.通过汇集生物样本估计基因-环境交互作用。
Stat Med. 2012 Nov 20;31(26):3241-52. doi: 10.1002/sim.5357. Epub 2012 Aug 1.
2
Assessment of skewed exposure in case-control studies with pooling.合并病例对照研究中偏倚暴露的评估。
Stat Med. 2012 Sep 28;31(22):2461-72. doi: 10.1002/sim.5351. Epub 2012 Mar 22.
3
Likelihood-based methods for regression analysis with binary exposure status assessed by pooling.基于似然比的方法用于通过合并来评估二元暴露状态的回归分析。
Stat Med. 2012 Sep 28;31(22):2485-97. doi: 10.1002/sim.4426. Epub 2012 Mar 13.
4
Pooling designs for outcomes under a Gaussian random effects model.高斯随机效应模型下结果的合并设计
Biometrics. 2012 Mar;68(1):45-52. doi: 10.1111/j.1541-0420.2011.01673.x. Epub 2011 Oct 9.
5
Logistic regression analysis of biomarker data subject to pooling and dichotomization.基于合并和二分法的生物标志物数据的逻辑回归分析。
Stat Med. 2012 Sep 28;31(22):2473-84. doi: 10.1002/sim.4367. Epub 2011 Sep 23.
6
Estimation and testing based on data subject to measurement errors: from parametric to non-parametric likelihood methods.基于受测量误差影响的数据的估计和检验：从参数似然法到非参数似然法。
Stat Med. 2012 Sep 28;31(22):2498-512. doi: 10.1002/sim.4304. Epub 2011 Jul 29.
7
Hybrid pooled-unpooled design for cost-efficient measurement of biomarkers.混合池化-非池化设计，用于经济高效地测量生物标志物。
Stat Med. 2010 Feb 28;29(5):597-613. doi: 10.1002/sim.3823.
8
Estimation of ROC curves based on stably distributed biomarkers subject to measurement error and pooling mixtures.基于存在测量误差且有混合样本的稳定分布生物标志物的ROC曲线估计
Stat Med. 2008 Jan 30;27(2):280-96. doi: 10.1002/sim.3035.
9
Pooling biospecimens and limits of detection: effects on ROC curve analysis.生物样本合并与检测限：对ROC曲线分析的影响
Biostatistics. 2006 Oct;7(4):585-98. doi: 10.1093/biostatistics/kxj027. Epub 2006 Mar 10.
10
ROC curve analysis for biomarkers based on pooled assessments.基于汇总评估的生物标志物的ROC曲线分析。
Stat Med. 2003 Aug 15;22(15):2515-27. doi: 10.1002/sim.1418.
Zotero 插件